Study type expertise

  • First-in-Man Trials
  • Intensive safety monitoring
  • Special patient population
  • Proof-of-concept
  • Drug-Drug interaction
  • Large healthy cohorts
  • Biosimilar/Bioequivalence
  • Long confinement
  • Food effect
  • Genotyping

Out Team experience

#

Therapeutic area

Number of studies

Phase

1 Bioequivalence studies 136 studies Phase I
2 Drug-Drug Interaction 118 studies Phase I
3 First-in-Man study 56 studies Phase I
4 Biosimilar 15 studies Phase I
5 Gastroenterology 11 studies Phase I
6 Gynecology 5 studies Phase I
7 Oncology 7 studies Phase I
8 Cardiovascular (hypertension, heat failure etc.) 22 studies Phase I-II
9 Respiratory (asthma, COPD) 41 studies Phase I-II
10 Metabolic disorders (type II diabetes, hypercholesterinaemia) 25 studies Phase I-II
11 Dermatology (acne, atopic dermatitis, psoriasis etc.) 11 studies Phase I-II
12 Rheumatoid arthritis 8 studies Phase II-III
13 Osteoarthritis 10 studies Phase II
14 Infections 7 studies Phase II